Esophageal metastasis of breast cancer during endocrine therapy for pleural dissemination 21 years after breast surgery: a case report

Miyake, Masuyo; Yamada, Akimitsu; Miyake, Kentaro; Endo, Itaru

doi:10.1186/s40792-019-0585-x

Surgical Case Reports

Table 1 Esophageal metastasis from breast cancer for the past 20 years

From: Esophageal metastasis of breast cancer during endocrine therapy for pleural dissemination 21 years after breast surgery: a case report

Ref No.	Year	Age	Sex	Primary site		Location	Length (cm)	DFS (year)	Latent interval (year)	Initial biopsy pathology	Synchronous other metastasis site	Treatment						Prognosis (month)	Status
Ref No.	Year	Age	Sex	ER/PgR	HER2	Location	Length (cm)	DFS (year)	Latent interval (year)	Initial biopsy pathology	Synchronous other metastasis site	C	E	O	R	S	D	Prognosis (month)	Status
5	1997	70	F	n/a	n/a	Mt	10	2	2	Benign	Local recurrence	○	○		○			36	Alive
6	1997	68	F	n/a	n/a	Mt	2	15	15	MBC	LN		○	○				12	Alive
7	1997	39	F	n/a	n/a	Lt, Ae	5	2	4	Benign	Lung, liver				○	○		4	Dead
8	1997	56	F	n/a	n/a	Lt	5	7	7	Benign	LN	○	○	○				48	Dead
9	1998	83	F	n/a	n/a	Ce	n/a	13	13	MBC	Liver		○				○	n/a	n/a
10	2001	73	F	n/a	n/a	Lt	7	9	9	MBC	n/a						○	12	Dead
10	2001	41	F	n/a	n/a	Mt	4	4	4	Benign	n/a	○				○	○	1	Dead
10	2001	77	F	n/a	n/a	Mt	n/a	3.5	3.5	Benign	n/a						○	18	Alive
10	2001	74	F	n/a	n/a	Mt	n/a	11	11	MBC	n/a					○	○	5	Dead
11	2002	55	F	n/a	n/a	Mt	n/a	11	11	Benign	None	○	○		○			36	Alive
12	2005	76	F	+	n/a	Ce	2	5	6	Benign	Bone	○	○			○		33	Alive
13	2005	72	F	n/a	n/a	Mt	n/a	23	23	Benign	None			○				12	Alive
13	2005	52	F	n/a	n/a	Lt	n/a	10	10	MBC	Pleura, lung, liver, adrenal gland, bone, brain		○			○	○	n/a	n/a
14	2005	68	F	n/a	n/a	Mt	n/a	23	23	Benign	None		○				○	14	Alive
15	2005	66	F	n/a	n/a	Ce	n/a	7	7	MBC	n/a	○			○			52	Dead
16	2006	67	F	n/a	n/a	EGJ	n/a	19	19	Benign	Lung		○	○				6	Alive
17	2009	70	F	+	n/a	Mt	3.5	16	16	MBC	None		○		○			30	Alive
18	2012	55	F	+	n/a	Ut, Mt	10	11	12	Undiagnosed	Local, LN	○						10	Alive
18	2012	61	F	+	–	Mt	7	6	8	MBC	Lung, pleura, LN, liver, brain	○						9	Alive
18	2012	64	F	+	–	Ut, Mt	n/a	4	9	Undiagnosed	Local, bone		○		○			6	Dead
18	2012	68	F	+	–	Mt	6	9	13	MBC	Bone, pleura	○						4	Alive
19	2013	61	F	n/a		Mt	n/a	15	15	MBC	None		○		○			n/a	n/a
1	2013	83	F	+	–	Mt	5	2	7	MBC	LN, lung	○				○		23	Dead
20	2014	79	F	n/a	n/a	Mt	3	15	26	MBC	None	○	○	○				96	Alive
21	2015	84	F	n/a	n/a	Lt	7	14	14	Benign	None	n/a						n/a	n/a
22	2015	62	F	n/a	n/a	Mt	5	13	13	Benign	None		○	○		○		60	Alive
Our	2018	77	F	+	n/a	Mt	5	21	21	MBC	Pleura		○		○			24	Alive

ER estrogen receptor, PgR Progesterone receptor, HER2 human epidermal growth factor 2, DFS disease-free survival, Ce cervical esophagus, Mt middle thoracic esophagus, Lt lower thoracic esophagus, Ae abdominal esophagus, EGJ esophagogastric junction, MBC metastasis of breast cancer, C chemotherapy, E endocrine therapy, O operation, R radiation, S stenting, D dilation, n/a not applicable

Back to article page